copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Prostate-Specific Antigen (PSA) Test - NCI Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland Both prostate cancer and several benign conditions (particularly benign prostatic hyperplasia, or BPH, and prostatitis) can cause PSA levels in the blood to rise The PSA test measures the level of PSA in the blood This test is used in several different ways: to monitor the
Understanding Prostate Changes - NCI - National Cancer Institute Learn about prostate changes and symptoms that are not cancer, plus risk factors and treatment for prostatitis, enlarged prostate (BPH), prostate cancer Talk with your doctor about prostate cancer screening tests (DRE, PSA)
Prostate Cancer Screening Results from PLCO - NCI Alteration of PSA cutoff level: Some researchers have suggested lowering the cut-off levels that determine if a PSA measurement is normal or elevated For example, a number of studies have used cut-off levels of 2 5 or 3 0 ng mL (rather than 4 0 ng mL) In such studies, PSA measurements above 2 5 or 3 0 ng mL are considered elevated
Prueba del antígeno prostático específico (PSA) Entérese de qué es una prueba del PSA, y de las limitaciones y los posibles daños de la prueba cuando se usa para detectar el cáncer de próstata
PSA Velocity Does Not Improve Prostate Cancer Detection A rapid increase in prostate-specific antigen (PSA) levels is not grounds for automatically recommending a prostate biopsy, according to a study published online February 24, 2011, in the Journal of the National Cancer Institute
Prostate Cancer Treatment - NCI Prostate-specific antigen (PSA) test: A test that measures the level of PSA in the blood PSA is a substance made by the prostate that may be found in higher than normal amounts in the blood of men who have prostate cancer
Prostate Cancer Screening | Cancer Trends Progress Report Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland The PSA test measures the level of PSA in a man’s blood For this test, a blood sample is sent to a laboratory for analysis In 2012 the U S Preventive Services Task Force (USPSTF) recommended against prostate cancer screening
Tumor Markers - NCI - National Cancer Institute Tumor markers can provide a wide variety of information that is important for cancer care, such as Helping to diagnose cancer However, having an elevated level of a tumor marker does not mean that someone has cancer Noncancerous conditions can sometimes cause an increase in the level of a tumor marker In addition, not everyone with a particular type of cancer will have a higher level of a
Tumor Markers - SEER Training After radical prostatectomy or radiation therapy, rising levels of PSA indicate residual disease or recurrence Note: test results may be affected by recent prostatic massage or palpation; PSA level should be assayed before digital rectal examination Normal range: 0 - 4 0 ng ml Normal range also varies depending on the patient's age
Tumor Markers - SEER Training Note: test results may be affected by recent prostatic massage or palpation; PSA level should be assayed before digital rectal examination Normal range: 0 - 4 0 ng ml Normal range also varies depending on the patient's age